Article
Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.
Antimicrobial agents and chemotherapy - 1 Sept 2017
Rahman Arfatur, Ferdous Sara Sabrina, Ahmed Shahriar, Rahman S M Mazidur, Uddin Mohammad Khaja Mafij, Pholwat Suporn, Gratz Jean, Houpt Eric, Banu Sayera
Abstract excerpt
Pyrazinamide (PZA) is a frontline antituberculosis (anti-TB) drug used in both first- and second-line treatment regimens. However, due to complex laboratory requirements, the PZA susceptibility test is rarely performed, leading to a scarcity of data on susceptibility to PZA. Bangladesh is a country with a burden of high rates of both TB and multidrug-resistant TB (MDR-TB), but to our knowledge, published data on...
Topics
Join the communities discussing this publication.
